WEST PHARMACEUTICAL SERVICES INC (WST) is a publicly traded company in the Unknown sector. Across all available filings, 42 corporate insiders have executed 1027 transactions totaling $277.8M, demonstrating a bearish sentiment with -$275.5M in net insider flow. The most recent transaction on Feb 20, 2026 involved a transaction of 89.33 shares valued at $0.
No significant insider buying has been recorded for WST in the recent period.
No significant insider selling has been recorded for WST in the recent period.
Based on recent SEC filings, insider sentiment for WST is bearish with an Insider Alignment Score of 0/100 and a net flow of -$275.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at WEST PHARMACEUTICAL SERVICES INC (WST) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 42 insiders are actively trading WST stock, having executed 1027 transactions in the past 90 days. The most active insider is Eric Mark Green (Executive), who has made 95 transactions totaling $196.2M.
Get notified when executives and directors at WST file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Winters Chad | VP, Chief Accounting Officer | Option Exercise | 89.33 | $N/A | $0 | |
| Feb 20, 2026 | Winters Chad | VP, Chief Accounting Officer | Payment | 30.18 | $241.12 | $7.3K | |
| Feb 20, 2026 | Winters Chad | VP, Chief Accounting Officer | Option Exercise | 89.33 | $N/A | $0 | |
| Feb 20, 2026 | Witherspoon Charles | VP & Treasurer | Option Exercise | 60.22 | $N/A | $0 | |
| Feb 20, 2026 | Witherspoon Charles | VP & Treasurer | Payment | 22.07 | $241.12 | $5.3K | |
| Feb 20, 2026 | Witherspoon Charles | VP & Treasurer | Option Exercise | 60.22 | $N/A | $0 | |
| Feb 20, 2026 | Jean Poussot Rodolphe | SVP, Strategy & Corporate Dev | Option Exercise | 383.38 | $N/A | $0 | |
| Feb 20, 2026 | Jean Poussot Rodolphe | SVP, Strategy & Corporate Dev | Payment | 129.55 | $241.12 | $31.2K | |
| Feb 20, 2026 | Jean Poussot Rodolphe | SVP, Strategy & Corporate Dev | Option Exercise | 383.38 | $N/A | $0 | |
| Feb 18, 2026 | F. Favorite Annette | Sr. VP & Chief HR Officer | Option Exercise | 135.49 | $N/A | $0 | |
| Feb 18, 2026 | F. Favorite Annette | Sr. VP & Chief HR Officer | Payment | 35.76 | $248.26 | $8.9K | |
| Feb 18, 2026 | F. Favorite Annette | Sr. VP & Chief HR Officer | Option Exercise | 135.49 | $N/A | $0 | |
| Feb 18, 2026 | Mark Green Eric | Executive | Option Exercise | 1,318.81 | $N/A | $0 | |
| Feb 18, 2026 | Mark Green Eric | Executive | Payment | 573.55 | $248.26 | $142.4K | |
| Feb 18, 2026 | Mark Green Eric | Executive | Option Exercise | 1,318.81 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 243 | $276.6M | 59.4% |
Exercise(M) | 190 | $82.2M | 17.6% |
Award(A) | 456 | $67.1M | 14.4% |
Payment(F) | 80 | $33.4M | 7.2% |
Gift(G) | 49 | $5.4M | 1.2% |
Purchase(P) | 7 | $1.1M | 0.2% |
Disposition(D) | 1 | $225.2K | 0.0% |
Discretionary(I) | 1 | $18.4K | 0.0% |
Insider selling pressure at WEST PHARMACEUTICAL SERVICES INC has increased, with 42 insiders executing 1027 transactions across all time. Total sales of $276.6M significantly outpace purchases of $1.1M, resulting in a net outflow of $275.5M. This selling activity appears largely discretionary, which may warrant closer attention from investors.